Phase I Study of Trastuzumab-DM1, an HER2 Antibody-Drug Conjugate, Given Every 3 Weeks to Patients With HER2-Positive Metastatic Breast Cancer
KROP, Ian E, BEERAM, Muralidhar, JACOBSON, Fred, LUTZKER, Stuart G, BURRIS, Howard A, MODI, Shanu, JONES, Suzanne F, HOLDEN, Scott N, WEI YU, GIRISH, Sandhya, TIBBITTS, Jay, YI, Joo-Hee, SLIWKOWSKI, Mark X
Published in Journal of clinical oncology (01.06.2010)
Published in Journal of clinical oncology (01.06.2010)
Get full text
Journal Article
Clinical pharmacology of trastuzumab emtansine (T-DM1): an antibody–drug conjugate in development for the treatment of HER2-positive cancer
Girish, Sandhya, Gupta, Manish, Wang, Bei, Lu, Dan, Krop, Ian E., Vogel, Charles L., Burris III, Howard A., LoRusso, Patricia M., Yi, Joo-Hee, Saad, Ola, Tong, Barbara, Chu, Yu-Waye, Holden, Scott, Joshi, Amita
Published in Cancer chemotherapy and pharmacology (01.05.2012)
Published in Cancer chemotherapy and pharmacology (01.05.2012)
Get full text
Journal Article
Clinical implications of pathophysiological and demographic covariates on the population pharmacokinetics of trastuzumab emtansine, a HER2-targeted antibody-drug conjugate, in patients with HER2-positive metastatic breast cancer
Gupta, Manish, Lorusso, Patricia M, Wang, Bei, Yi, Joo-Hee, Burris, 3rd, Howard A, Beeram, Muralidhar, Modi, Shanu, Chu, Yu-Waye, Agresta, Samuel, Klencke, Barbara, Joshi, Amita, Girish, Sandhya
Published in Journal of clinical pharmacology (01.05.2012)
Published in Journal of clinical pharmacology (01.05.2012)
Get more information
Journal Article
A target-mediated model to describe the pharmacokinetics and hemodynamic effects of recombinant human vascular endothelial growth factor in humans
Eppler, Stephen M, Combs, Daniel L, Henry, Timothy D, Lopez, John J, Ellis, Stephen G, Yi, Joo-Hee, Annex, Brian H, McCluskey, Edward R, Zioncheck, Thomas F
Published in Clinical pharmacology and therapeutics (01.07.2002)
Published in Clinical pharmacology and therapeutics (01.07.2002)
Get more information
Journal Article
Drug interaction potential of trastuzumab emtansine (T-DM1) combined with pertuzumab in patients with HER2-positive metastatic breast cancer
Lu, Dan, Burris, 3rd, Howard A, Wang, Bei, Dees, E Claire, Cortes, Javier, Joshi, Amita, Gupta, Manish, Yi, Joo-Hee, Chu, Yu-Waye, Shih, Ted, Fang, Liang, Girish, Sandhya
Published in Current drug metabolism (01.09.2012)
Published in Current drug metabolism (01.09.2012)
Get more information
Journal Article
Preclinical safety profile of trastuzumab emtansine (T-DM1): Mechanism of action of its cytotoxic component retained with improved tolerability
Poon, Kirsten Achilles, Flagella, Kelly, Beyer, Joseph, Tibbitts, Jay, Kaur, Surinder, Saad, Ola, Yi, Joo-Hee, Girish, Sandhya, Dybdal, Noel, Reynolds, Theresa
Published in Toxicology and applied pharmacology (01.12.2013)
Published in Toxicology and applied pharmacology (01.12.2013)
Get full text
Journal Article
Effects of Trastuzumab Emtansine (T-DM1) on QT Interval and Safety of Pertuzumab Plus T-DM1 in Patients With Previously Treated Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer
Gupta, Manish, Wang, Bei, Carrothers, Timothy J, LoRusso, Patricia M, Chu, Yu-Waye, Shih, Ted, Loecke, David, Joshi, Amita, Saad, Ola, Yi, Joo-Hee, Girish, Sandhya
Published in Clinical pharmacology in drug development (01.01.2013)
Published in Clinical pharmacology in drug development (01.01.2013)
Get more information
Journal Article
Population pharmacokinetics of trastuzumab emtansine (T-DM1), a HER2-targeted antibody–drug conjugate, in patients with HER2-positive metastatic breast cancer: clinical implications of the effect of covariates
Lu, Dan, Girish, Sandhya, Gao, Yuying, Wang, Bei, Yi, Joo-Hee, Guardino, Ellie, Samant, Meghna, Cobleigh, Melody, Rimawi, Mothaffar, Conte, Pierfranco, Jin, Jin Yan
Published in Cancer chemotherapy and pharmacology (01.08.2014)
Published in Cancer chemotherapy and pharmacology (01.08.2014)
Get full text
Journal Article
An Integrated Multiple-Analyte Pharmacokinetic Model to Characterize Trastuzumab Emtansine (T-DM1) Clearance Pathways and to Evaluate Reduced Pharmacokinetic Sampling in Patients with HER2-Positive Metastatic Breast Cancer
Lu, Dan, Joshi, Amita, Wang, Bei, Olsen, Steve, Yi, Joo-Hee, Krop, Ian E., Burris, Howard A., Girish, Sandhya
Published in Clinical pharmacokinetics (01.08.2013)
Published in Clinical pharmacokinetics (01.08.2013)
Get full text
Journal Article
PK assays for antibody-drug conjugates: case study with ado-trastuzumab emtansine
Dere, Randall, Yi, Joo-Hee, Lei, Corinna, Saad, Ola M, Huang, Catherine, Li, Yanhong, Baudys, Jakub, Kaur, Surinder
Published in Bioanalysis (01.05.2013)
Published in Bioanalysis (01.05.2013)
Get full text
Journal Article
Immunogenicity assays for antibody-drug conjugates: case study with ado-trastuzumab emtansine
Carrasco-Triguero, Montserrat, Yi, Joo-Hee, Dere, Randall, Qiu, Zhihua Julia, Lei, Corinna, Li, Yanhong, Mahood, Connie, Wang, Bei, Leipold, Douglas, Poon, Kirsten Achilles, Kaur, Surinder
Published in Bioanalysis (01.05.2013)
Published in Bioanalysis (01.05.2013)
Get full text
Journal Article
Overcoming soluble target interference in an anti-therapeutic antibody screening assay for an antibody-drug conjugate therapeutic
Carrasco-Triguero, Montserrat, Mahood, Connie, Milojic-Blair, Marija, Amaya, Caroline, Ruppel, Jane, Hong, Kyu, Yi, Joo-Hee, Kaur, Surinder
Published in Bioanalysis (01.08.2012)
Published in Bioanalysis (01.08.2012)
Get more information
Journal Article
Abstract P4-15-09: Phase 1 study of trastuzumab emtansine in HER2-positive metastatic breast cancer patients with normal or reduced hepatic function
Li, Chunze, Agarwal, Priya, Dent, Susan, Goncalves, Anthony, Yi, Joo-Hee, Strasak, Alexander, Green, Marjorie, Girish, Sandhya, LoRusso, Pat
Published in Cancer research (Chicago, Ill.) (01.05.2015)
Published in Cancer research (Chicago, Ill.) (01.05.2015)
Get full text
Journal Article